Introduction: Mycobacterium ulcerans is the etiological agent of Buruli ulcer (BU) the third most common mycobacterial infection in humans after tuberculosis and leprosy. BU is now considered by the WHO to be an emerging infection of major concern. M. ulcerans produces mycolactone toxin, which is required for the organism’s virulence. Mycolactone destroys tissue and suppresses host immune responses. Methods: In this descriptive analytical study, peripheral blood mononuclear cells from three volunteers with no history of buruli ulcer were used. IL-6 and TNF produced by these cells at different preincubation times with LPS and mycolactone were measured by using ELISA kits. Results: This study showed hyper inhibition of IL-6 and TNF production...
<div><p>Infection with <i>Mycobacterium ulcerans</i> is characterised by tissue necrosis and immunos...
BACKGROUND: Buruli ulcer (BU) is a neglected necrotizing disease of the skin, subcutaneous tissue an...
Mycolactone is a polyketide macrolide lipid-like secondary metabolite synthesized by Mycobacterium u...
International audienceMycobacterium ulcerans causes Buruli ulcer, a neglected tropical skin disease ...
International audienceMycolactone, a lipid-like toxin, is the major virulence factor of Mycobacteriu...
The pathogenicity of Mycobacterium ulcerans, the agent of Buruli ulcer, depends on the cytotoxic exo...
Mycolactone, a lipid-like toxin, is the major virulence factor of Mycobacterium ulcerans, the etiolo...
Buruli ulcer (BU) is the third most common mycobacterial disease in immunocompetent hosts. BU is cau...
International audienceMycolactone is a polyketide toxin produced by Mycobacterium ulcerans (Mu), the...
Buruli ulcer (BU) is a progressive necrotising skin disease caused by Mycobacterium ulcerans. The ba...
International audienceBuruli ulcer disease (BUD) is an emerging human disease caused by infection wi...
The acquisition by a Mycobacterium marinum-like progenitor of a plasmid encoding enzymes for the bio...
Infection of subcutaneous tissue with Mycobacterium ulcerans can lead to chronic skin ulceration kno...
Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a devastating necrotizing skin disease. Key ...
Background: Buruli ulcer is a disease of the skin and soft tissues caused by infection with a slow g...
<div><p>Infection with <i>Mycobacterium ulcerans</i> is characterised by tissue necrosis and immunos...
BACKGROUND: Buruli ulcer (BU) is a neglected necrotizing disease of the skin, subcutaneous tissue an...
Mycolactone is a polyketide macrolide lipid-like secondary metabolite synthesized by Mycobacterium u...
International audienceMycobacterium ulcerans causes Buruli ulcer, a neglected tropical skin disease ...
International audienceMycolactone, a lipid-like toxin, is the major virulence factor of Mycobacteriu...
The pathogenicity of Mycobacterium ulcerans, the agent of Buruli ulcer, depends on the cytotoxic exo...
Mycolactone, a lipid-like toxin, is the major virulence factor of Mycobacterium ulcerans, the etiolo...
Buruli ulcer (BU) is the third most common mycobacterial disease in immunocompetent hosts. BU is cau...
International audienceMycolactone is a polyketide toxin produced by Mycobacterium ulcerans (Mu), the...
Buruli ulcer (BU) is a progressive necrotising skin disease caused by Mycobacterium ulcerans. The ba...
International audienceBuruli ulcer disease (BUD) is an emerging human disease caused by infection wi...
The acquisition by a Mycobacterium marinum-like progenitor of a plasmid encoding enzymes for the bio...
Infection of subcutaneous tissue with Mycobacterium ulcerans can lead to chronic skin ulceration kno...
Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a devastating necrotizing skin disease. Key ...
Background: Buruli ulcer is a disease of the skin and soft tissues caused by infection with a slow g...
<div><p>Infection with <i>Mycobacterium ulcerans</i> is characterised by tissue necrosis and immunos...
BACKGROUND: Buruli ulcer (BU) is a neglected necrotizing disease of the skin, subcutaneous tissue an...
Mycolactone is a polyketide macrolide lipid-like secondary metabolite synthesized by Mycobacterium u...